Bemarituzumab in Patients with Fgfr2B-Selected Gastric or Gastro-Oesophageal Junction Adenocarcinoma (Fight) : a Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study

AuthID
P-00X-D3K
21
Author(s)
Wainberg, ZA
·
Enzinger, PC
·
Qin, SK
·
Yamaguchi, K
·
Kim, IH
·
Saeed, A
·
Oh, SC
·
Li, J
·
Turk, HM
·
[+1]·
Hitre, E
·
Udrea, AA
·
Sanchez, RG
·
Mitra, S
·
Yang, YS
·
Lee, KW
Tipo de Documento
Article
Year published
2022
Publicado
in LANCET ONCOLOGY, ISSN: 1470-2045
Volume: 23, Número: 11, Páginas: 1430-1440 (11)
Indexing
Publication Identifiers
Pubmed: 36244398
SCOPUS: 2-s2.0-85140889719
Wos: WOS:000886922400038
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Wainberg, ZA;   2 Enzinger, PC;   3 Kang, YK;
4 Qin, SK;   5 Yamaguchi, K;   6 Kim, IH;
7 Saeed, A;   8 Oh, SC;   9 Li, J;
10 Turk, HM;   11 Teixeira, A;   12 Borg, C;
13 Hitre, E;   14 Udrea, AA;   15 Cardellino, GG;
16 Sanchez, RG;   17 Collins, H;   18 Mitra, S;
19 Yang, YS;   20 Catenacci, DVT;   21 Lee, KW;